Shigeki Miyamoto

13.1k total citations · 1 hit paper
157 papers, 8.8k citations indexed

About

Shigeki Miyamoto is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Shigeki Miyamoto has authored 157 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Molecular Biology, 64 papers in Cancer Research and 41 papers in Immunology. Recurrent topics in Shigeki Miyamoto's work include NF-κB Signaling Pathways (58 papers), Multiple Myeloma Research and Treatments (17 papers) and Immune Response and Inflammation (17 papers). Shigeki Miyamoto is often cited by papers focused on NF-κB Signaling Pathways (58 papers), Multiple Myeloma Research and Treatments (17 papers) and Immune Response and Inflammation (17 papers). Shigeki Miyamoto collaborates with scholars based in United States, Japan and Greece. Shigeki Miyamoto's co-authors include Inder M. Verma, Zhao‐Hui Wu, Edward M. Schwarz, Jennifer K. Stevenson, Tony T. Huang, Shelly M. Wuerzberger‐Davis, Paul J. Chiao, Stuart D. Shumway, Yuling Shi and I M Verma and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Shigeki Miyamoto

152 papers receiving 8.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.

1995 1.6k citations Inder M. Verma, Shigeki Miyamoto et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shigeki Miyamoto United States	42	5.1k	3.9k	3.0k	2.1k	526	157	8.8k
Brydon L. Bennett United States	35	4.5k 0.9×	3.1k 0.8×	3.0k 1.0×	1.8k 0.8×	509 1.0×	62	8.8k
Anthony M. Manning United States	29	4.6k 0.9×	3.1k 0.8×	2.8k 0.9×	1.8k 0.8×	551 1.0×	55	8.6k
Gwyn T. Williams United Kingdom	41	6.0k 1.2×	2.7k 0.7×	3.0k 1.0×	1.8k 0.8×	339 0.6×	121	10.1k
Frank Mercurio United States	36	7.8k 1.5×	5.4k 1.4×	4.5k 1.5×	3.3k 1.5×	660 1.3×	53	12.6k
Daniel Krappmann Germany	50	4.8k 0.9×	3.7k 1.0×	3.6k 1.2×	2.2k 1.0×	473 0.9×	104	9.0k
Gail E. Sonenshein United States	62	6.7k 1.3×	3.3k 0.9×	2.3k 0.8×	2.8k 1.3×	660 1.3×	155	10.9k
Lawrence M. Pfeffer United States	54	5.4k 1.1×	3.1k 0.8×	3.6k 1.2×	3.2k 1.5×	475 0.9×	193	10.7k
David R. Plas United States	35	5.6k 1.1×	3.0k 0.8×	2.6k 0.9×	1.7k 0.8×	476 0.9×	64	8.9k
Giovanni Melillo United States	44	4.1k 0.8×	3.3k 0.9×	1.5k 0.5×	2.1k 1.0×	268 0.5×	102	7.9k
Vinay Tergaonkar Singapore	61	6.4k 1.3×	3.3k 0.8×	2.5k 0.8×	1.9k 0.9×	675 1.3×	122	10.5k

Countries citing papers authored by Shigeki Miyamoto

Since Specialization

Citations

This map shows the geographic impact of Shigeki Miyamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeki Miyamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeki Miyamoto more than expected).

Fields of papers citing papers by Shigeki Miyamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeki Miyamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeki Miyamoto. The network helps show where Shigeki Miyamoto may publish in the future.

Co-authorship network of co-authors of Shigeki Miyamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeki Miyamoto. A scholar is included among the top collaborators of Shigeki Miyamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeki Miyamoto. Shigeki Miyamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maqueda, María, Teresa Lobo‐Jarne, José Yélamos, et al.. (2025). NEMO is essential for directing the kinases IKKα and ATM to the sites of DNA damage. Science Signaling. 18(877). eadr0128–eadr0128. 2 indexed citations

Warrick, Jay W., et al.. (2022). A Hyaluronan and Proteoglycan Link Protein 1 Matrikine: Role of Matrix Metalloproteinase 2 in Multiple Myeloma NF-κB Activation and Drug Resistance. Molecular Cancer Research. 20(9). 1456–1466. 11 indexed citations

Callander, Natalie S., et al.. (2022). Timelapse viability assay to detect division and death of primary multiple myeloma cells in response to drug treatments with single cell resolution. Integrative Biology. 14(3). 49–61. 1 indexed citations

Wuerzberger‐Davis, Shelly M., et al.. (2022). Ectopic CH60 mediates HAPLN1-induced cell survival signaling in multiple myeloma. Life Science Alliance. 6(3). e202201636–e202201636. 2 indexed citations

Wuerzberger‐Davis, Shelly M., et al.. (2019). CRISPR/Cas9-based editing of a sensitive transcriptional regulatory element to achieve cell type-specific knockdown of the NEMO scaffold protein. PLoS ONE. 14(9). e0222588–e0222588. 9 indexed citations

Pagenkopf, Adam, Binod Dhakal, Chelsea Hope, et al.. (2017). Versican (VCAN) Proteolysis Predicts T-Cell Infiltration in Myeloma Bone Marrow Post- Autologous Stem Cell Transplant (ASCT). Blood. 130. 1756–1756. 1 indexed citations

Jensen, Jeffrey L., Alexander L. Rakhmilevich, Erika Héninger, et al.. (2015). Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma. Cancer Immunology Research. 3(8). 881–890. 22 indexed citations

Miyamoto, Shigeki, et al.. (2012). A case of anti-BP180-type mucous membrane pemphigoid difficult to distinguish from bullous pemphigoid. Japanese Journal of Oral & Maxillofacial Surgery. 58(5). 297–301. 1 indexed citations

Yang, Yibin, Fang Xia, Nicole Hermance, et al.. (2011). A Cytosolic ATM/NEMO/RIP1 Complex Recruits TAK1 To Mediate the NF-κB and p38 Mitogen-Activated Protein Kinase (MAPK)/MAPK-Activated Protein 2 Responses to DNA Damage. Molecular and Cellular Biology. 31(14). 2774–2786. 118 indexed citations

10.

Markovina, Stephanie, Natalie S. Callander, Shelby L. O’Connor, et al.. (2008). Bortezomib-Resistant Nuclear Factor-κB Activity in Multiple Myeloma Cells. Molecular Cancer Research. 6(8). 1356–1364. 118 indexed citations

11.

Wu, Zhao‐Hui, William C. Florence, Vrajesh V. Parekh, et al.. (2008). Cutting Edge: K63-Linked Polyubiquitination of NEMO Modulates TLR Signaling and Inflammation In Vivo. The Journal of Immunology. 180(11). 7107–7111. 38 indexed citations

12.

Draheim, Kyle, et al.. (2006). NFKB1 Is a Direct Target of the TAL1 Oncoprotein in Human T Leukemia Cells. Cancer Research. 66(12). 6008–6013. 21 indexed citations

13.

O’Connor, Shelby L., Stuart D. Shumway, Ian J. Amanna, Colleen E. Hayes, & Shigeki Miyamoto. (2004). Regulation of Constitutive p50/c-Rel Activity via Proteasome Inhibitor-Resistant IκBα Degradation in B Cells. Molecular and Cellular Biology. 24(11). 4895–4908. 33 indexed citations

14.

Huang, Tony T. & Shigeki Miyamoto. (2001). Postrepression Activation of NF-κB Requires the Amino-Terminal Nuclear Export Signal Specific to IκBα. Molecular and Cellular Biology. 21(14). 4737–4747. 90 indexed citations

15.

Hashimoto, Keitaro, et al.. (2000). Block of Na exchangers on ischemia induced arrhythmias. 20. 1 indexed citations

16.

Seufzer, Bradley J., et al.. (2000). A Switch in Distinct IκBα Degradation Mechanisms Mediates Constitutive NF-κB Activation in Mature B Cells. The Journal of Immunology. 164(9). 4762–4767. 23 indexed citations

17.

Miyamoto, Shigeki, Bradley J. Seufzer, & Stuart D. Shumway. (1998). Novel IκBα Proteolytic Pathway in WEHI231 Immature B Cells. Molecular and Cellular Biology. 18(1). 19–29. 112 indexed citations

18.

Kawada, T, Teruyuki Koyama, Shigeki Miyamoto, et al.. (1996). Operative Results of Stanford Type A Aortic Dissection Associated with a Compromised Coronary Artery. Annals of Thoracic and Cardiovascular Surgery. 2(4). 255–260. 1 indexed citations

19.

Shimada, F, Hideichi Makino, Shigeki Miyamoto, et al.. (1995). Identification of two novel amino acid polymorphisms in beta-cell/liver (GLUT2) glucose transporter in Japanese subjects. Diabetologia. 38(2). 211–215. 11 indexed citations

20.

Miyamoto, Shigeki, Keith A. Cauley, & Inder M. Verma. (1995). [43] Ultraviolet cross-linking of DNA binding proteins. Methods in enzymology on CD-ROM/Methods in enzymology. 254. 632–641. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact